05:31 AM EDT, 03/25/2026 (MT Newswires) -- Royal Philips (PHG) said Wednesday it has launched its IntraSight Plus interventional cardiology guidance platform.

The product has received clearance for clinical use in the US and Europe. It helps clinicians with diagnosis, virtually plan treatment, guide device placement and verify results all on a single screen.

The company said IntraSight Plus' commercial availability is subject to market release and applicable regulatory requirements.

Philips shares were up 2.8% in premarket activity.